Improved SVR rates in Southeast Asians with chronic hepatitis C treated with PEG-interferon and ribavirin

被引:0
|
作者
Nguyen, TT [1 ]
Rothstein, KD [1 ]
Araya, V [1 ]
机构
[1] Albert Einstein Med Ctr, Philadelphia, PA 19141 USA
来源
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2005年 / 100卷 / 09期
关键词
D O I
10.14309/00000434-200509001-00367
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
367
引用
收藏
页码:S144 / S144
页数:1
相关论文
共 50 条
  • [1] 72 week peg-interferon/ribavirin therapy improved SVR rates in hepatitis C patients with incomplete EVR
    Gilliver, R.
    Hansen, R.
    Jones, B. E.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 107 - 107
  • [2] 72 week Peg-interferon/ribavirin therapy improved SVR rates in hepatitis C patients with incomplete EVR
    Gilliver, R.
    Hansen, R.
    Jones, B. E.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A135 - A135
  • [3] THERAPEUTIC RESPONSE TO PEG-INTERFERON PLUS RIBAVIRIN IN CHRONIC HEPATITIS C
    Harja-Alexa, Ioana-Alina
    Luca, Mihaela-Catalina
    Manciuc, Carmen Doina
    Vata, A.
    Badescu, Aida
    Hurmuzache, M. E.
    Ciocan, Alexandra Mirela
    Hunea, Ioana Maria
    Trofin, Felicia
    Iancu, Luminita Smaranda
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2019, 123 (04): : 615 - 622
  • [4] The effect of statins on PEG-interferon/ribavirin treatment for chronic hepatitis C
    Yen, Roy D.
    Prabhu, Anoop
    Mahl, Thomas
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S217 - S217
  • [5] Treatment with PEG-interferon and ribavirin therapy in dialysis patients with chronic hepatitis C
    Tan, Adriaan C.
    de Vries, Richard A.
    Adang, Rob
    Konings, Stijn
    Cnossen, Nynke
    Schalm, Solko W.
    van Leusen, Rob
    HEPATOLOGY, 2006, 44 (04) : 321A - 321A
  • [6] COULD PEG-INTERFERON AND RIBAVIRIN BE EFFECTIVE AND SAFE IN THALASSEMIC PATIENTS WITH CHRONIC HEPATITIS C?
    Madonia, S.
    Barone, R.
    Pantalone, G. Restivo
    Sinagra, E.
    Perricone, G.
    Renda, M. C.
    Piazza, A.
    Maggio, A.
    Cottone, M.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S351 - S352
  • [7] MULTICENTRE TRIAL OF PEG-INTERFERON α2A & RIBAVIRIN IN PEDIATRIC CHRONIC HEPATITIS C
    Sokal, Etienne M.
    Bourgois, Annick
    Stephenne, Xavier
    Porta, Gilda
    Silveira, Themis R.
    Gordovska, Dace
    Fischler, Bjorn
    Kelly, Deirdre A.
    HEPATOLOGY, 2009, 50 (04) : 418A - 419A
  • [8] Reversible alopecia universalis during treatment with PEG-interferon and ribavirin for chronic hepatitis C
    Taliani, G
    Biliotti, E
    Capanni, M
    Tozzi, A
    Bresci, S
    Pimpinelli, N
    JOURNAL OF CHEMOTHERAPY, 2005, 17 (02) : 212 - 214
  • [9] Treatment with PEG-interferon and Ribavirin for Chronic Hepatitis C Increases Neutrophil and Monocyte Chemotaxis
    Giorgini, Alessia
    Capsoni, Franco
    Podda, Mauro
    Lleo, Ana
    Battezzati, Pier Maria
    Ongari, Anna Maria
    Selmi, Carlo
    Benetti, Alberto
    Malinverno, Federica
    Rossaro, Lorenzo
    Gershwin, M. Eric
    Zuin, Massimo
    CONTEMPORARY CHALLENGES IN AUTOIMMUNITY, 2009, 1173 : 847 - 857
  • [10] Treatment with PEG-interferon and ribavirin for chronic hepatitis C does not decrease neutrophil and monocyte activity
    Giorgini, A.
    Capsoni, F.
    Lleo, A.
    Selmi, C.
    Ongari, A. M.
    Benetti, A.
    Ferrari, B.
    Invernizzi, P.
    Podda, M.
    Zuin, M.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S198 - S198